ABSTRACT
INTRODUCTION
There have been very few reports about allergy to fish roe. In western countries, there have been a few case reports, one reporting an anaphylaxis to caviar 1 and the other a severe IgE-mediated reaction to the roe of 2 species. 2 '-component . In a report using sera from several SR allergic patients, the beta'-component was identified as the main allergen. 3 We were burdened with devising a diet for patients allergic to CE or fish if they asked to eat SR. We also have no answer as to whether SR anaphylactic pa-tients can eat different kinds of fish roe safely. The cross-reactivity among fish roe was investigated using a CAP-RAST system 4 6 The protein concentrations of these samples were determined by a BCA protein assay ( Pierce , Rockford, IL, USA)
In Japan, even though salmon roe (SR) is listed as a 'recommended for allergic labeling' food because of some patient reports of anaphylaxis to SR, there have been no scientific reports on its allergenicity. Generally, fish roe consists of yolk and vitelline, while there is no protein corresponding to the white of chicken eggs (CE). In fish, the yolk proteins originating from vitellogenin are classified as lipovitellin, phosvitin and a beta

MEASUREMENT OF SPECIFIC IGE ANTIBODIES TO EXTRACTS FROM FISH, ROE AND CHICKEN EGG WHITE ( CEW ) USING THE RADIOALLER-GOSORBENT TEST (RAST)
The freeze-dried samples were dissolved in 25 ml coupling buffer ( 0.1 M NaHCO3, 0.5 M NaCl ) and centrifuged at 13,000 rpm ( 20000 xg 
Re l a t i o n s h i p o f t h e s p e c i f i c I g E v a l u e b e t we e n s a l mo n a n d s a l mo n r o e ( A) a n d b et we e n s a l mo n r o e a n d c h i c k e n e g g wh i t e
( B) . I g E v a l u e s o f e a c h e x t r a c t we r e me a s u r e d b y r a d i o a l l e r g o s o r b e n t t e s t ( RA S T ) i n s e r u m f r o m 2 7 f i s h a l l e r g y p a t i e n t s a n d 2 6 n o n -f i s h a ll e r g y p a t i e n t s ( c o n t r o l s u b j e c t s ) . Wh e n t h e I g E v a l u e s o f b o t h e x t r a c t s we r e l e s s t h a n t h e me a n＋ 2 S D o f t h e c o n t r o l s u b j e c t s , t h e s a mp l e wa s e x c l u d e d f r o m t h i s s t u d y .
T h e r e we r e n o s i g n i f i c a n t r e l a t i o n s h i p s o f I g E v a l u e s b e t we e n s a l mo n a n d s a l mo n r o e ( R= 0 . 0 0 3 ) , a n d b e t we e n s a l mo n r o e a n d c h i c k e n e g g wh i t e ( R= 0 . 0 8 7 ) . (Fig . 1A) , AND BE-TWEEN SR AND CEW IN THE RAST STUDY (Fig.  1B) We measured the IgE value to each extract in the serum of fish allergy patients and control subjects . When the IgE values to both extracts were less than the mean + 2SD of the control subjects, the sample was excluded from this study . Finally , 27 patients were enrolled, as shown in Figure 1A , and 21 samples were used, as shown in Figure 1B . There were no relationships in the IgE values between salmon and SR ( R = 0.003) or between SR and CEW ( R = 0.087)
RESULTS
THE RELATIONSHIP OF THE IgE VALUES BE-TWEEN SALMON AND SR
e l a t i o n s b e t we e n s a l mo n r o e a n d h e r r i n g r o e ( R= 0 . 6 0 0 ) a n d b e t we e n s a l mo n r o e a n d p o l l o c k r o e ( R= 0 . 7 8 8 
ELISA INHIBITION
As shown in Figures 3A, B Figure 3C , (Fig. 4) i g . 3 E L I S A i n h i b i t i o n b e t we e n s a l mo n r o e ( S R) a n d v a r i o u s a n t i g e n ( s a l mo n , h e r r i n g r o e : HR, p o l l o c k r o e : P R o r c h i c k e n e g g y o l k : CE Y ) u s i n g s e r a f r o m t wo p a t i e n t s wh o h a d a n a p h y l a c t i c r e a c t i o n s t o s a l mo n e g g ( A a n d B) , a n d s e r a f r o m a p a t i e n t wi t h f i s h a l l e r g y wh o h a d n o a l l e r g i c r e a c t i o n s t o S R b u t a v o i d e d S R b e c a u s e t h e I g E v a l u e o f s a l mo n , S R, c h i c k e n e g g wh i t e we r e h i g h ( C) . I n t h e t wo s e r a f r o m p a t i e n t s wi t h a n a p h y l a x i s t o S R ( A, B) , t h e b i n d i n g o f I g E t o S R wa s i n h i b i t e d mo r e t h a n 5 0 % b y p r e -i n c u b a t i o n o f t h e s er u m wi t h HR a n d a l mo s t 5 0 % b y t h o s e wi t h P R i n a d o s e d e p e n d e n t ma n n e r ; h o we v e r , n o e f f i c i e n t i n h i b i t i o n o f I g E t o S R wa s s e e n b y p r e -i n c u b a t i o n wi t h CE Y o r a n i s a k i s . S a l mo n i n h i b i t e d t h e I g E b i n d i n g t o S R mo r e t h a n 5 0 % i n p a t i e n t A. On t h e o t h e r h a n d , i n t h e s e r a f r o m p a t i e n t C t h e I g E b i n d i n g t o e a c h e x t r a c t wa s n o t i n h i b i t e d b y p r e -i n c u b a t i o n o f t h e s e r u m wi t h a n y h e t e r o g e n e i t y e x t r a c t . 10 The same results were seen in our RAST study . Moreover , Tanaka et al. reported Figure 3C . Our data were different from previous data. 5 This 
CEW also did not efficiently inhibit the binding of IgE to SR (data not shown). Because the binding of IgE to salmon and CEY was quite low, the assessment of inhibition of these two allergens was not possible. Inhibition of the IgE binding to SR was achieved more than 50% by salmon in patient A. In another patient (B), inhibition of the IgE to SR was achieved nearly 50% by salmon inhibitor at one level below the maximum concentration . Because the solution of salmon inhibitor was very sticky, testing the maximum concentration ( 10,000 μg! ml ) was not possible As shown in
the binding of IgE to each extract in patients who avoided SR because of the high IgE values to salmon, SR and CEW, was not inhibited by any heterogeneity inhibitor.
IMMUNOBLOTTING OF SR WITH SERA FROM 3 PATIENTS
The IgE binding patterns to SR on the membrane were different between patients with anaphylaxis to SR and without any anaphylactic episodes to SR. The two anaphylactic patients reacted to the protein with relatively low molecular weight bands (15 and 17 kDa), while the patient with no episodes of hypersensitivity to SR reacted to that with a relatively high molecular weight protein band (21 kDa ). Partial protein sequences of these bands were determined and screened for homology with sequences in the Swiss
l o t o f s a l mo n r o e wi t h s e r a f r o m t h e s a me p a t i e n t s d e s c r i b e d i n F i g u r e 3 . T h e I g E b i n d i n g p a t t e r n s we r e d i f f e r e n t b e t we e n t h e p a t ie n t s wi t h a n a p h y l a x i s t o s a l mo n r o e ( A a n d B ) a n d f i s h a ll e r g y wi t h o u t a n a p h y l a c t i c e p i s o d e s t o s a l mo n r o e
( C) . B o t h I g E f r o m a n a p h y l a x i s p a t i e n t s b o u n d t o r e l a t i v e l y l o w mol e c u l a r we i g h t p r o t e i n b a n d s , wh i l e I g E f r o m t h e f i s h a l l e r g y p a t i e n t r e a c t e d wi t h t h e r e l a t i v e l y h i g h mo l e c u l a r we i g h t p r ot e i n b a n d . Ou t l i n e d a n d s o l i d s t a r s i n d i c a t e t h e p r o t e i n b an d s o f s a l mo n r o e t h a t we r e s t r o n g l y b o u n d b y t h e p a t i e n t ' s I g E .
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